Literature DB >> 961467

Prevalence of hypercalcaemia in a health screening in Stockholm.

T Christensson, K Hellström, B Wengle, A Alveryd, B Wikland.   

Abstract

A free health check, offered to 21417 20-63-year-old employees of the Stockholm City and County Council in 1971-73, was accepted by 15903 persons. The examination included a multichannel chemical analysis of a single blood sample. Serum calcium levels greater than or equal to 11.0 mg/100 ml (2.75 mmol/l) and greater than or equal to 11.1 mg/100 ml (2.78 mmol/l) were encountered in 3.9% and 1.1% of the population, respectively. Among subjects below 50 years of age, the calcium concentration was significantly higher in males than in females. This difference disappeared in older subjects, essentially because the calcium level decreased with advancing age in the men. To a further investigation were invited 178 subjects with a single serum calcium registration greater than or equal to 11.1 mg/100 ml (2.78 mmol/l). Of this group, 95 persons (53.4%) exhibited hypercalcaemia (HC) on repeated testing. Twelve had been operated on prior to the actural follow-up and found to have parathyroid adenomata. Twenty subjects were on continuous treatment with diuretics of the thiazide type and seven had diseases that might induce HC (two had hyperthyroidism, two hypothyroidism, one sarcoidosis, one hypernephroma and one mammary carcinoma). In 56 patients the laboratory and physical examinations did not reveal any obvious cause for the HC except possible hyperparathyoidism (HPT). Eighty (84.2%) of the 95 HC subjects were women, mostly over 50 years. The 95 persons constituted 6% of the total number of health-screened persons. The highest prevalence, 13%, was recorded for women aged 60-63. The prevalence of HPT in the total material was 3.6%, which is higher than that found in several other studies. This is based on surgical findings to date.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 961467     DOI: 10.1111/j.0954-6820.1976.tb08208.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  32 in total

1.  West Germany: still an underdeveloped country in the diagnosis and early treatment of primary hyperparathyroidism?

Authors:  C Dotzenrath; P E Goretzki; H D Röher
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Intraoperative parathyroid hormone estimation: a valuable adjunct to parathyroid surgery.

Authors:  G S Robertson; S J Iqbal; A Bolia; P R Bell; P S Veitch
Journal:  Ann R Coll Surg Engl       Date:  1992-01       Impact factor: 1.891

3.  Cholelithiasis in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening.

Authors:  T Christensson; K Einarsson
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

Review 4.  Antacid-induced osteomalacia.

Authors:  Y Boutsen; J P Devogelaer; J Malghem; H Noel; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 5.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

6.  Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.

Authors:  Helene Siilin; Ewa Lundgren; Hans Mallmin; Dan Mellström; Claes Ohlsson; Magnus Karlsson; Eric Orwoll; Osten Ljunggren
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

7.  Determinants of serum calcium in men and women. The Tromsø Study.

Authors:  R Jorde; J Sundsfjord; K H Bønaa
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

8.  The diagnosis and management of hyperparathyroidism during pregnancy.

Authors:  A A Deutsch; M Zager; J Bernheim; Z Steiner; R Reiss
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

9.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 10.  Asymptomatic primary hyperparathyroidism.

Authors:  B J Harrison; M H Wheeler
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.